HR+ Breast Cancer
Oncology·MeSH: Endometrial Neoplasms
Prevalence
289.8 / 100K
Incidence
30.4 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target HR+ Breast Cancer?
There are 1 clinical trial targeting HR+ Breast Cancer tracked by BioSniper.
What is the prevalence of HR+ Breast Cancer?
The estimated prevalence of HR+ Breast Cancer is approximately 289.8 per 100,000 population.
Deep-dive into HR+ Breast Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis